119 related articles for article (PubMed ID: 3560190)
1. Autoantibodies to albumin in the plasma of patients with diabetes mellitus. Relationship with circulating immune complexes.
Triolo G; Giardina E; Rinaldi A; Seddio G; Bompiani GD
J Clin Lab Immunol; 1986 Nov; 21(3):113-5. PubMed ID: 3560190
[TBL] [Abstract][Full Text] [Related]
2. Islet cell antibodies, circulating immune complexes and antinuclear antibodies in diabetes mellitus.
Helmke K; Otten A; Mäser E; Wolf H; Federlin K
Horm Metab Res; 1987 Jul; 19(7):312-5. PubMed ID: 3305275
[TBL] [Abstract][Full Text] [Related]
3. Analysis of IgA1 and IgA2 subclass distribution in IgA- containing circulating immune complexes in patients with diabetes mellitus.
Triolo G; Giardina E; Seddio G; Terrizzi C
Boll Ist Sieroter Milan; 1987; 66(2):116-9. PubMed ID: 3311077
[TBL] [Abstract][Full Text] [Related]
4. Collagen binding activity in sera of patients with insulin-dependent (type 1) and non insulin-dependent (type 2) diabetes mellitus.
Triolo G; Giardina E; Bompiani GD
J Clin Lab Immunol; 1988 Jul; 26(3):121-4. PubMed ID: 3230579
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma levels of IgA-IgG immune complexes and anti-F(ab')2 antibodies in patients with type 2 (non insulin-dependent) diabetes mellitus and microangiopathy.
Casiglia D; Giardina E; Scarantino G; Triolo G
Diabetes Res; 1990 Dec; 15(4):195-200. PubMed ID: 2132409
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies, immunoglobulins, complement and circulating immune complexes in acute malaria.
Jhaveri KN; Ghosh K; Mohanty D; Parmar BD; Surati RR; Camoens HM; Joshi SH; Iyer YS; Desai A; Badakere SS
Natl Med J India; 1997; 10(1):5-7. PubMed ID: 9069696
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes, insulin antibodies, and deposits of immunoglobulins in the skin in diabetes.
Josephsen PG; Permin H; Juhl F; Enk B; Svehag SE
Dan Med Bull; 1986 Jun; 33(3):171-4. PubMed ID: 3720367
[TBL] [Abstract][Full Text] [Related]
8. [Circulating immune complexes in the blood of diabetics with diabetic retinopathies].
Saldan IR; Vanichkin AA; Mikhel'tseva IN
Oftalmol Zh; 1986; (1):45-7. PubMed ID: 3703449
[No Abstract] [Full Text] [Related]
9. Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor.
Triolo G; Giardina E; Casiglia D; Scarantino G; Bompiani GD
Clin Exp Immunol; 1991 Apr; 84(1):53-8. PubMed ID: 2015712
[TBL] [Abstract][Full Text] [Related]
10. [Immune reactions and vascular complications in diabetes mellitus].
Triolo G
Recenti Prog Med; 1987 Jan; 78(1):36-8. PubMed ID: 3589119
[No Abstract] [Full Text] [Related]
11. [Disorders of the hormonal and immune status of patients with newly detected diabetes mellitus].
Dubrovskaia GV; Malyzhev VA; Sakalo EA
Vrach Delo; 1989 Aug; (8):58-60. PubMed ID: 2588531
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
[TBL] [Abstract][Full Text] [Related]
13. Specific immunoregulation abnormality in insulin-dependent diabetes mellitus.
Fairchild RS; Kyner JL; Abdou NI
J Lab Clin Med; 1982 Feb; 99(2):175-86. PubMed ID: 6460826
[TBL] [Abstract][Full Text] [Related]
14. Complement component 3 (C 3) and diabetes mellitus.
Krantz S; Stelter F; Lober M; Rjasanowski I; Michaelis D; Buske B
Exp Clin Endocrinol; 1988 Mar; 92(3):287-96. PubMed ID: 3253105
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies.
Rasheed Z; Ali R
Life Sci; 2006 Nov; 79(24):2320-8. PubMed ID: 16945391
[TBL] [Abstract][Full Text] [Related]
16. Significance of ICSA in the development of diabetes mellitus.
Ohagi S; Nanjo K; Kawaguchi T; Sowa R; Miyano M; Kondo M; Sanke T; Kawa A; Miyarura K
J Med Assoc Thai; 1987 Mar; 70 Suppl 2():104-8. PubMed ID: 3598414
[No Abstract] [Full Text] [Related]
17. Circulating immune complexes in diabetic patients with periodontitis.
Anil S; Remani P; Ankathil R; Vijayakumar T
Ann Dent; 1990; 49(2):3-5, 45. PubMed ID: 2278478
[TBL] [Abstract][Full Text] [Related]
18. Humoral immune abnormalities in human brucellosis.
Gotuzzo E; Bocanegra TS; Alarcón GS; Carrillo C; Espinoza LR
Allergol Immunopathol (Madr); 1985; 13(5):417-24. PubMed ID: 4083235
[TBL] [Abstract][Full Text] [Related]
19. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE
Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960
[TBL] [Abstract][Full Text] [Related]
20. [Circulating immune complexes and insulin-binding capacity of the serum of diabetics].
Vel'bri SK; Lilleorg AL; Kerge IaKh
Probl Endokrinol (Mosk); 1986; 32(2):25-8. PubMed ID: 3520540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
